Pasar al contenido principal


Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting

Noticias

Dr. Reddy’s at 5th CII LIFE SCIENCES SUMMIT 2023 - Making India a Global Pharma and Lifesciences Innovation Hub

Dr. Reddys at 5th CII LIFE SCIENCES SUMMIT 2023

Mr. Gunjan Singh, VP & Head (Europe & U.S.), API Sales and Marketing at Dr. Reddys API, shared profound insights at the recent summit themed "Making India a Global Pharma and Lifesciences Innovation Hub." His comprehensive coverage included pivotal topics such as evolving business models, bridging academia-industry gaps, fermenting technology for robust API manufacturing, enforcing the new Schedule M, and fostering a new Indian vaccine ecosystem.

Mr. Gunjan Singh, VP & Head (Europe & U.S.)

Gunjan Singh emphasized India's potential for self-sufficiency in API and outlined strategies for achieving cost competitiveness. Intellectual property rights were underscored as a key focus area for long-term results. His invaluable recommendations have garnered widespread appreciation from participants and stakeholders within the Pharma and Biotech industry.

The summit witnessed the convergence of senior Government officials, policymakers, key industry experts, innovators, and academicians. Together, they deliberated to propel India into an Innovation Hub in the Lifesciences Sector.

Making India a Global Pharma and Lifesciences Innovation Hub

  • Business Evolution: Exploring new business models for Lifesciences innovation.
  • Academia-Industry Synergy: Strengthening collaboration between academic research and industry.
  • Technological Advancements: Development of fermentation technology for enhanced API manufacturing.
  • Regulatory Framework: Insights on the impact of the new Schedule M.

Mr. Gunjan Singh's contribution at the summit marks a significant step forward in shaping the future of India's Pharma and Biotech landscape. The collaborative efforts showcased the nation's commitment to becoming a global leader in Lifesciences innovation.

Media Coverage Click here.

Contact Us

Rellene el siguiente formulario y nos pondremos en contacto con usted a la brevedad.

Nuestra lienea de contacto email: api@drreddys.com | +91 40 49002222

Renuncia

Ninguna información en este sitio web, incluyendo cualquier referencia a cualquier producto o servicio, constituye una oferta de venta ni se interpretará como tal. Los productos protegidos por patentes válidas no se ofrecen ni suministran para uso comercial. Sin embargo, en ciertos casos, a discreción exclusiva de Dr. Reddy's y sujeto a los requisitos legales locales, las cantidades de investigación de dichos productos pueden ofrecerse para fines de presentaciones regulatorias según la Sección 107A de la Ley de Patentes de la India (exención de Bolar), donde existan dichas exenciones regulatorias. Los compradores deben realizar su propia evaluación del producto o servicio, incluyendo el escenario de patentes en sus respectivos mercados, y serán responsables de todas las responsabilidades relacionadas con las patentes. Dr. Reddy's renuncia a todas las garantías, expresas o implícitas, incluyendo, entre otras, las garantías de comerciabilidad, idoneidad para un propósito particular y no infracción.

Empresa

Contactenos

Follow Us on

  • Twitter

Dr. Reddy’s Laboratories, 8-2-337,
Banjara Hills Rd Number 3,
SBI Executive Enclave, Green Valley,
Banjara Hills, Hyderabad,
Telangana 500034
Phone: 040 4900 2222

© 2025 Dr. Reddy’s Laboratories Ltd. All rights reserved.

Dr. Reddy’s Laboratories, 8-2-337,
Banjara Hills Rd Number 3,
SBI Executive Enclave, Green Valley,
Banjara Hills, Hyderabad,
Telangana 500034
Phone: 040 4900 2222

  • Twitter

© 2025 Dr. Reddy’s Laboratories Ltd.
All rights reserved.

X

Let’s talk API sourcing live at

Tackle sourcing bottlenecks and compliance hurdles

Hall E1 Booth H28 24-26 June 2025, Shanghai

Book a Meeting